Delivery of infusion fluids for cytostatic drugs
Original notice title
Poland – Pharmaceutical products – Dostawy płynów infuzyjnych do pracowni leków cytostatycznych
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Award Criteria
Lot 1
Lot 2
Lot 3
Lot 4
Lot 5
Lot 6
Lot 7
Buyer
Name
Wojewódzki Szpital Specjalistyczny w Legnicy
Location
LEGNICA, POL
Website
Buyer profile
Identifier
691-22-04-853
Lots (7)
LOT-0001
CZĘŚĆ 1
GLUCOSUM 5% (worek 250 ml)
Location
Duration
Category
Selection criteria
Award details
LOT-0002
CZĘŚĆ 2
GLUCOSUM 5% (worek 500 ml)
Location
Duration
Category
Selection criteria
Award details
LOT-0003
CZĘŚĆ 3
NATRIUM CHLORATUM 0,9% (worek 50 ml)
Location
Duration
Category
Selection criteria
Award details
LOT-0004
CZĘŚĆ 4
NATRIUM CHLORATUM 0,9% (worek 100 ml)
Location
Duration
Category
Selection criteria
Award details
LOT-0005
CZĘŚĆ 5
NATRIUM CHLORATUM 0,9% (worek 250 ml)
Location
Duration
Category
Selection criteria
Award details
LOT-0006
CZĘŚĆ 6
NATRIUM CHLORATUM 0,9% (worek 500 ml)
Location
Duration
Category
Selection criteria
Award details
LOT-0007
CZĘŚĆ 7
NATRIUM CHLORATUM 0,9% (worek 1000 ml)
Location
Duration
Category
Selection criteria
Award details
Procurement Details
- Publication date
- 21 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Polish
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 425563-2026
Documents (1)
Similar tenders
Denmark – Pharmaceutical products – Amgros 2027 1.1051.b
Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie
Romania – Pharmaceutical products – MEDICAMENTE - PRODUSE FARMACEUTICE
Denmark – Pharmaceutical products – Amgros 2027 1.1052.b
Latvia – Pharmaceutical products – Par reģistrēto un nereģistrēto medikamentu piegādi Elektronisko iepirkumu sistēmas dalībniekiem
Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications